Your browser doesn't support javascript.
loading
Influenza Antiviral Treatment and Length of Stay.
Campbell, Angela P; Tokars, Jerome I; Reynolds, Sue; Garg, Shikha; Kirley, Pam Daily; Miller, Lisa; Yousey-Hindes, Kimberly; Anderson, Evan J; Oni, Oluwakemi; Monroe, Maya; Kim, Sue; Lynfield, Ruth; Smelser, Chad; Muse, Alison T; Felsen, Christina; Billing, Laurie M; Thomas, Ann; Mermel, Elizabeth; Lindegren, Mary Lou; Schaffner, William; Price, Andrea; Fry, Alicia M.
Afiliação
  • Campbell AP; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia app4@cdc.gov.
  • Tokars JI; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Reynolds S; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Garg S; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Kirley PD; California Emerging Infections Program, Oakland, California.
  • Miller L; Communicable Disease Branch, Colorado Department of Public Health and Environment, Denver, Colorado.
  • Yousey-Hindes K; Connecticut Emerging Infections Program, Yale School of Public Health, Yale University, New Haven, Connecticut.
  • Anderson EJ; Pediatrics and Medicine, Emory University School of Medicine and the Atlanta Veterans Affairs Medical Center, Atlanta, Georgia.
  • Oni O; Iowa Department of Public Health, Des Moines, Iowa.
  • Monroe M; Emerging Infections Program, Maryland Department of Health, Baltimore, Maryland.
  • Kim S; Communicable Disease Division, Michigan Department of Health and Human Services, Lansing, Michigan.
  • Lynfield R; Minnesota Department of Health, St Paul, Minnesota.
  • Smelser C; New Mexico Department of Health, Santa Fe, New Mexico.
  • Muse AT; New York State Department of Health, Albany, New York.
  • Felsen C; University of Rochester Medical Center, Rochester, New York.
  • Billing LM; Bureau of Infectious Diseases, Ohio Department of Health, Columbus, Ohio.
  • Thomas A; Oregon Public Health Division, Portland, Oregon.
  • Mermel E; Rhode Island Department of Health, Providence, Rhode Island.
  • Lindegren ML; Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Schaffner W; Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Price A; Bureau of Epidemiology, Salt Lake County Health Department, Salt Lake City, Utah.
  • Fry AM; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Pediatrics ; 148(4)2021 10.
Article em En | MEDLINE | ID: mdl-34470815
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Influenza Humana / Tempo de Internação Tipo de estudo: Guideline / Prognostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Pediatrics Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Geórgia País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Influenza Humana / Tempo de Internação Tipo de estudo: Guideline / Prognostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Pediatrics Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Geórgia País de publicação: Estados Unidos